Choose Your Language:
Posted by: The Sumaira Foundation in News & Announcements
January 27, 2025 — The Sumaira Foundation is pleased to welcome Dr. Jeffrey Bennett, Professor of Neurology & Ophthalmology, from the University of Colorado School of Medicine to join TSF’s international Medical Advisory Board.
Dr. Jeffrey L. Bennett is the Gertrude Gilden Professor for Neurodegenerative Disease Research in the Departments of Neurology and Ophthalmology at the University of Colorado School of Medicine. He is also a faculty member of the Programs in Immunology and Neuroscience, and the Rocky Mountain MS Center at Anschutz Medical Campus.
Dr. Bennett received his medical and doctoral degrees at Stanford University and completed his internship and residency in Neurology at the University of Colorado and completed a clinical fellowship in neuro-ophthalmology at the University of Pennsylvania.
Dr. Bennett directs basic, translational, and clinical research programs on neuromyelitis optica spectrum disorder (NMOSD), multiple sclerosis MS), optic neuritis, and MOGAD, and maintains active specialty practices in neuro-ophthalmology and neuro-immunology. He has received the Stephen Reingold Award from the National Multiple Sclerosis Society, the CU Inventor of the Year Award from the University of Colorado, and Top Doctor awards from Best Doctors in America, America’s Top Physicians, Castle Connolly, and US News and World Report.
Dr. Bennett has been a leader in understanding the role of B cells and autoantibodies in autoimmune disorders of the central nervous system. His laboratory’s research in NMOSD has elucidated the pathogenicity of AQP4 autoantibodies and myelin targeted autoantibodies in MS. In addition, Dr. Bennett actively participates in clinical research. He has designed clinical trial protocols for the diagnosis and treatment of optic neuritis in NMOSD, participated on the steering committee member for 3 sponsored clinical trials in NMOSD (NMOmentum, SakuraStar, and CHAMPIONS), and is currently working as a principal investigator on two ongoing clinical trials in MOGAD.
Dr. Bennett has authored over 190 peer-reviewed manuscripts in the fields of neuro-immunology and neuro-ophthalmology. He is a member of the 2015 and 2025 International Panel on NMO Diagnosis and the 2023 International Panel on Diagnosis of MOGAD. He is currently on the editorial board for the Journal of Neuro-Ophthalmology, Multiple Sclerosis Journal, Neurology: Neuroimmunology & Neuroinflammation, and the Annals of Neurology.
